menu
    • menu

    Company profile for Cybrexa Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cybrexa was founded by physician-scientists and an experienced management team that has built numerous successful life sciences ventures. We are an oncology-focused platform technology company that enables antigen-independent targeting of tumors and metastases with deep tissue penetration for small molecule anti-cancer drugs. We’re passionate about bringing new treatment options to help more cancer patients live longer, more...
    Cybrexa was founded by physician-scientists and an experienced management team that has built numerous successful life sciences ventures. We are an oncology-focused platform technology company that enables antigen-independent targeting of tumors and metastases with deep tissue penetration for small molecule anti-cancer drugs. We’re passionate about bringing new treatment options to help more cancer patients live longer, more fulfilling lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cybrexa TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5 Science Park 395 Winchester Ave. New Haven, CT 06511
    Telephone
    Telephone
    (860) 717-2731
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cybrexa.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cybrexa-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cybrexa Shares Preclinical Data On Tumor-Targeting Peptide Drugs
    Cybrexa Shares Preclinical Data On Tumor-Targeting Peptide Drugs

    04 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/04/3036388/0/en/Cybrexa-Therapeutics-Announces-New-Preclinical-Data-on-Tumor-Selective-Peptide-Drug-Conjugates-at-ESMO-Targeted-Anticancer-Therapies-Congress-2025.html

    GLOBENEWSWIRE
    04 Mar 2025
    Share Share
    Cybrexa Doses First Patient In CBX-12 Phase 2 Ovarian Cancer Trial
    Cybrexa Doses First Patient In CBX-12 Phase 2 Ovarian Cancer Trial

    07 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/07/2958808/0/en/Cybrexa-Therapeutics-Announces-First-Patient-Dosed-with-First-in-Class-Peptide-Drug-Conjugate-CBX-12-in-Phase-2-Trial-in-Ovarian-Cancer.html

    GLOBENEWSWIRE
    07 Oct 2024
    Share Share
    Cybrexa Announces CBX-12 Phase 1 Data At ESMO 2024
    Cybrexa Announces CBX-12 Phase 1 Data At ESMO 2024

    16 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/16/2946456/0/en/Cybrexa-Therapeutics-Announces-Positive-Final-Data-at-ESMO-2024-from-Phase-1-Study-of-Peptide-Drug-Conjugate-CBX-12-in-Advanced-Solid-Tumors.html

    GLOBENEWSWIRE
    16 Sep 2024
    Share Share
    John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor
    John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor

    25 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/25/2903762/0/en/Industry-Leader-John-Maraganore-Ph-D-Joins-Cybrexa-Therapeutics-as-Strategic-Advisor.html

    GLOBENEWSWIRE
    25 Jun 2024
    Share Share
    Cybrexa Regains Rights to CBX-12
    Cybrexa Regains Rights to CBX-12

    06 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/06/2824260/0/en/Cybrexa-Regains-Rights-to-CBX-12.html

    GLOBENEWSWIRE
    06 Feb 2024
    Share Share
    Cybrexa Therapeutics to Debut Preclinical Data Demonstrating CBX-15 is Safe
    Cybrexa Therapeutics to Debut Preclinical Data Demonstrating CBX-15 is Safe

    10 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/10/2757453/0/en/Cybrexa-Therapeutics-to-Debut-Preclinical-Data-Demonstrating-CBX-15-is-Safe-and-Highly-Efficacious-in-13762-Triple-Negative-Breast-Cancer-Model-at-35th-AACR-NCI-EORTC-Symposium.html

    GLOBENEWSWIRE
    10 Oct 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search